China Hypertension Alliance Grass-roots Council set up a peak set up "hypertension community prevention and control training fund"
Release time:
2020-07-22
China Hypertension Alliance Basic Level Council Established
Peak Established "Hypertension Community Prevention Training Fund "
News 10 17-20 , 2019 China Hypertension Annual Conference and 21 International Hypertension and Related Diseases Symposium Held in Xiamen, during this period, the grass-roots council of the China Hypertension Alliance was established. Jianfeng Group invested ,100 yuan to set up "Hypertension Community Prevention and Control Training Fund " for relevant training and study of grass-roots doctors.
China Hypertension Alliance is the only member of the World Hypertension Alliance (WHL ) in China. It has been committed to publicizing hypertension knowledge, carrying out prevention and treatment of hypertension diseases, and carrying out relevant academic exchanges and scientific research at home and abroad. According to statistics, at present, the incidence rate of hypertension among the population aged , 18 and 32 in China is , 27.9, , and the population suffering from hypertension is , 2.45 .6 billion. However, the awareness rate, treatment rate and control rate of patients are still very low, which has become a difficult problem for the whole society, therefore, the "Healthy China 2030 Planning Outline" specifically proposes to strive to increase the awareness rate, treatment rate and control rate of hypertension to 70% , 99% and 50% respectively by 2030 . To this end, the China Hypertension League established a secondary branch "China Hypertension League Grassroots Council " , dedicated to the prevention and management of hypertension at the grassroots level. To support this work, Jianfeng Group funded the establishment of "Hypertension Community Prevention Training Fund " . Jiang Xiaomeng, chairman of
Group Company and chairman of Jianfeng Pharmaceutical Co., Ltd., said in his speech at the ceremony that Jianfeng Pharmaceutical Co., Ltd. has always made unremitting efforts in the community hypertension prevention and training fund in line with the enterprise spirit of "to set up a high-quality medicine " , and has always taken the promotion of people's health as its own responsibility. The establishment of "community hypertension prevention and treatment training fund " aims to carry out multi-level and wide coverage of basic hypertension standardized diagnosis and treatment training, long-term management of grass-roots hypertension and other topics of training and continuing education, and make efforts to improve the hypertension management level of grass-roots health and medical institutions and grass-roots doctors.
is the mainstream antihypertensive drug in the current Chinese market. Jianfeng Pharmaceutical's CCB class antihypertensive drug aspartate amlodipine tablets (Leisid) has attracted widespread attention and won unanimous praise from the experts attending the meeting due to its unique effects of double-effect integration and smooth antihypertensive effect. (Zhou Wenyi Fang Wentong)
More information
On the afternoon of June 9, Peak Cable Company organized all employees to learn fire fighting knowledge and conducted fire fighting and emergency escape drills. Since June, the subordinate enterprises of the company have organized training, learning and drills related to production safety according to their own characteristics and combined with the actual work. Safety production month series of activities carried out in an orderly manner.
2022
06-13
Spike Postdoctoral Research Papers on International Frontier Journals
Recently, good news came from the postdoctoral workstation of Jianfeng Pharmaceutical. Under the guidance of workstation mentor Jiang Xiaomeng, associate researcher Yang Xiaoxiao has made new progress in the treatment of alcoholic liver disease. The relevant research results "Roxadustat, a hypoxia-inducible factor 1a activator, attenuates both long- and short-term alcohol induced alcoholic liver disease" were published in the internationally renowned academic journal "Frontiers in Pharmacology. This journal is a frontier journal in the field of international pharmacy, mainly publishing academic papers and information on basic and clinical pharmacology, medicinal chemistry, pharmacology and toxicology.
2022
06-01
Daye Peak QC Achievements Won the Third Prize of Huangshi City
On May 7, Huangshi City Quality Strong City Working Committee organized a 2022 QC Results Conference. The QC project of "Technical Transformation of Ore Limestone Batching System" of Daye Peak Cement Company won the third prize.
2022
06-01
On April 28, Dalian Commodity Exchange held an online working meeting to announce the results of the 2021 excellent delivery warehouse and delivery warehouse excellent futures personnel selection, peak international trading company won the 2021 "excellent designated delivery warehouse" title, futures commissioner Ruan Weihang won the "excellent futures personnel" title.
2022
06-01
Cranberry extract combination identification detection method won the invention patent
After cranberry extract products were included in the "Zhejiang Province Key High-tech Product Development Project Plan" in 2021, Jianfeng Health Technology Company recently obtained an invention patent for the identification and detection method of cranberry extract. This new combined identification and detection method developed by Jianfeng Health identifies whether catechin or procyanidin B2 is added in cranberry extract by thin layer analysis, and then detects the unique A- type procyanidin and its chromatographic distribution in cranberry extract by high performance liquid chromatography, so as to improve the accuracy of product judgment. The identification method has the characteristics of accurate results and short detection time, which is of great significance to standardize the cranberry extract market and promote the healthy development of the industry, and has been unanimously recognized by peers.
2022
05-20
Daye Peak Manufacturing Department Won the Title of "Worker Pioneer" in Hubei Province
A few days ago, the manufacturing department of Daye Peak Cement Company was awarded the title of "Worker Pioneer" by the Hubei Provincial Federation of Trade Unions. Daye Jianfeng Manufacturing Department not only continued to actively explore and achieved good results in energy saving and consumption reduction, technological transformation, product quality process control, and economic responsibility system to guide management, but also improved Daye Jianfeng's overall operation level and won Huangshi City The seventh "Mayor Quality Award" created conditions and was fully affirmed by government departments at all levels.
2022
05-20
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page